TIAA CREF Investment Management LLC lowered its stake in shares of LifePoint Health (NASDAQ:LPNT) by 6.1% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 131,028 shares of the company’s stock after selling 8,483 shares during the quarter. TIAA CREF Investment Management LLC owned 0.33% of LifePoint Health worth $6,525,000 at the end of the most recent quarter.
Other institutional investors also recently bought and sold shares of the company. Cerebellum GP LLC purchased a new stake in shares of LifePoint Health during the 4th quarter valued at $126,000. State of Alaska Department of Revenue purchased a new stake in shares of LifePoint Health during the 4th quarter valued at $134,000. US Bancorp DE raised its position in shares of LifePoint Health by 62.4% during the 4th quarter. US Bancorp DE now owns 3,095 shares of the company’s stock valued at $155,000 after buying an additional 1,189 shares in the last quarter. OxFORD Asset Management LLP purchased a new position in LifePoint Health in the 3rd quarter worth $303,000. Finally, Stone Ridge Asset Management LLC purchased a new position in LifePoint Health in the 4th quarter worth $326,000.
A number of equities analysts recently commented on the stock. BidaskClub upgraded shares of LifePoint Health from a “sell” rating to a “hold” rating in a research report on Thursday, January 11th. Mizuho reiterated a “hold” rating and issued a $51.00 target price on shares of LifePoint Health in a research report on Thursday, March 22nd. Robert W. Baird reiterated a “buy” rating and issued a $54.00 target price on shares of LifePoint Health in a research report on Tuesday, March 27th. Royal Bank of Canada decreased their target price on shares of LifePoint Health to $58.00 and set an “outperform” rating on the stock in a research report on Monday, February 26th. Finally, Morgan Stanley reiterated an “equal weight” rating and issued a $46.00 target price (down previously from $50.00) on shares of LifePoint Health in a research report on Monday, February 26th. One research analyst has rated the stock with a sell rating, thirteen have assigned a hold rating and seven have given a buy rating to the company’s stock. The stock currently has an average rating of “Hold” and an average price target of $54.31.
Shares of LifePoint Health stock opened at $48.05 on Friday. The firm has a market capitalization of $1,867.03, a price-to-earnings ratio of 13.24, a PEG ratio of 1.46 and a beta of 0.50. LifePoint Health has a 12-month low of $41.45 and a 12-month high of $67.95. The company has a debt-to-equity ratio of 1.26, a quick ratio of 1.49 and a current ratio of 1.70.
LifePoint Health (NASDAQ:LPNT) last announced its quarterly earnings results on Friday, February 23rd. The company reported $0.77 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.81 by ($0.04). The firm had revenue of $1.49 billion during the quarter, compared to the consensus estimate of $1.58 billion. LifePoint Health had a return on equity of 6.34% and a net margin of 1.46%. LifePoint Health’s revenue was down 7.2% on a year-over-year basis. During the same period last year, the business earned $1.07 EPS. research analysts expect that LifePoint Health will post 4.23 earnings per share for the current fiscal year.
In other news, Chairman William F. Carpenter III purchased 21,368 shares of the business’s stock in a transaction on Wednesday, February 28th. The shares were acquired at an average price of $46.80 per share, with a total value of $1,000,022.40. Following the acquisition, the chairman now directly owns 482,668 shares in the company, valued at $22,588,862.40. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, insider David M. Dill sold 45,000 shares of the firm’s stock in a transaction on Tuesday, January 16th. The stock was sold at an average price of $48.52, for a total transaction of $2,183,400.00. Following the completion of the sale, the insider now directly owns 252,673 shares in the company, valued at approximately $12,259,693.96. The disclosure for this sale can be found here. 8.76% of the stock is owned by company insiders.
TRADEMARK VIOLATION WARNING: “TIAA CREF Investment Management LLC Lowers Stake in LifePoint Health (LPNT)” was originally published by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are reading this news story on another site, it was stolen and republished in violation of US and international copyright & trademark laws. The correct version of this news story can be viewed at https://www.dispatchtribunal.com/2018/04/15/tiaa-cref-investment-management-llc-lowers-stake-in-lifepoint-health-lpnt.html.
About LifePoint Health
LifePoint Health, Inc, through its subsidiaries, owns and operates community hospitals, regional health systems, physician practices, outpatient centers, and post-acute facilities in the United States. Its hospitals provide a range of medical and surgical services, such as general surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic care, coronary care, rehabilitation, and pediatric, as well as specialized services, including open-heart surgery, skilled nursing, psychiatric care, and neuro-surgery.
Want to see what other hedge funds are holding LPNT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for LifePoint Health (NASDAQ:LPNT).
Receive News & Ratings for LifePoint Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifePoint Health and related companies with MarketBeat.com's FREE daily email newsletter.